Monocacy Therapeutics Inc. — Form D

Monocacy Therapeutics Inc. of MONROVIA, MD, a company, filed a Form D exempt-offering notice with the SEC on 2026-05-27. $114K was reported sold. Industry: Biotechnology.

Offering

• Filed: 2026-05-27
• Form: D
• Accession: 0002137361-26-000001
• Industry: Biotechnology
• Exemptions: 06b
• Amount sold: $114K
• Minimum investment: $10K
• Investors: 2
• Revenue range: Decline to Disclose
• SEC file number: 021-585336

Issuer

• Name: Monocacy Therapeutics Inc.
• CIK: 0002137361
• Entity type: Corporation
• Jurisdiction: DELAWARE
• Address: 4716 MONROVIA BLVD, MONROVIA, MD, 21770
• Phone: 3019790911

Officers, directors & promoters (1)

More

• CIK 2137361 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search